Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hôpital Érasme (hôpital Universitaire de Bruxelles)
Brussels, Belgium
Gilles Naeije
- University of Campinas
Campinas, São Paulo, Brazil
Marcondes França
- Centre Hospitalier de L'Universite de Montreal Chum
Montreal, Quebec, Canada
Antoine Duquette
- Institut Du Cerveau Et de la Moelle Epinière
Paris, France
Alexandra Durr
- Hospital Sant Joan de Deu
Barcelona, Spain
Alejandra Darling
- University of California Los Angeles
Los Angeles, California, United States
Susan Perlman - University of Iowa
Iowa City, Iowa, United States
Katherine Mathews - Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
David Lynch
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2026
- Primary completion
- 15 Mar 2029
- Completion
- 15 Mar 2029
- Last update posted
- 14 Aug 2026
- Registered enrollment
- 120
- Registry id
- NCT07681713
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.